APA aipamena

Messersmith, W. A., Jimeno, A., Ettinger, D., Laheru, D., Brahmer, J., Lansey, D., . . . Hidalgo, M. (2008). Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.

Chicago Style aipamena

Messersmith, Wells A., et al. Phase I Trial of Weekly Trabectedin (ET-743) and Gemcitabine in Patients With Advanced Solid Tumors. 2008.

MLA aipamena

Messersmith, Wells A., et al. Phase I Trial of Weekly Trabectedin (ET-743) and Gemcitabine in Patients With Advanced Solid Tumors. 2008.